We had evaluated DNA methylation of the CDKN2A promoter CpG island as a cancer indicator, but found substantial DNA methylation in AdjNTL, and no significant difference between AdjNTL and cancer (data not shown). The gene discussed is CDKN2A; the disease is cancer.